These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Extended survival of purified canine islet allografts with heterologous antilymphocyte globulin. Kaufman DB; Morel P; Field MJ; Roney M; Condie R; Sutherland DE Transplant Proc; 1991 Feb; 23(1 Pt 1):761-3. PubMed ID: 1990682 [No Abstract] [Full Text] [Related]
4. Beneficial and detrimental effects of RBC-adsorbed antilymphocyte globulin and prednisone on purified canine islet autograft and allograft function. Kaufman DB; Morel P; Condie R; Field MJ; Rooney M; Tzardis P; Stock P; Sutherland DE Transplantation; 1991 Jan; 51(1):37-42. PubMed ID: 1987703 [TBL] [Abstract][Full Text] [Related]
5. Islet cell transplantation: important factors contributing to optimal pancreatic function. Toledo-Pereyra LH; Bandlien KO; Amiel J P R Health Sci J; 1987 Aug; 6(2):101-6. PubMed ID: 3118405 [TBL] [Abstract][Full Text] [Related]
6. Transplantation of islet cells. Toledo-Pereyra LH; Gordon DA; MacKenzie GH Surg Gynecol Obstet; 1984 Jan; 158(1):49-56. PubMed ID: 6419360 [TBL] [Abstract][Full Text] [Related]
7. Active enhancement of dog kidney allografts using ALG and donor platelets. Rowiński W; Ryffa T; Stepkowski S; Woźniewicz B; Ruka M; Wasowska B; Hay M; Olszewski W Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1013-9. PubMed ID: 373670 [TBL] [Abstract][Full Text] [Related]
8. Renal subcapsular islet cell transplantation. Toledo-Pereyra LH; Bandlien KO; Gordon DA; MacKenzie GH; Reyman TA Am Surg; 1985 Dec; 51(12):721-9. PubMed ID: 3000237 [TBL] [Abstract][Full Text] [Related]
9. Failure to demonstrate a synergistic effect between enhancing serum and ALS in recipients of pancreatic islet allografts. Finch DR; Morris PJ Transplantation; 1977 Apr; 23(4):386-8. PubMed ID: 405761 [No Abstract] [Full Text] [Related]
11. Successful intrathymic allografts of porcine pancreatic islets without continuous immunosuppression. Kenmochi T; Une S; Miyamoto M; Nakagawa Y; Benhamou PY; Mullen Y Transplant Proc; 1995 Feb; 27(1):145-7. PubMed ID: 7878939 [No Abstract] [Full Text] [Related]
12. Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction. Pegrum GD; Williams G; Markwick J; Barnes RM Postgrad Med J; 1976; 52(5 Suppl):47-50. PubMed ID: 11454 [TBL] [Abstract][Full Text] [Related]
13. Effect of antilymphocyte serum on crude pancreatic islet allograft survival. Gotoh M; Maki T; Satomi S; Porter J; Monaco AP Transplant Proc; 1987 Feb; 19(1 Pt 1):576-7. PubMed ID: 3152704 [No Abstract] [Full Text] [Related]
14. Successful engraftment of autologous and allogeneic islets into the porcine thymus. Watt PC; Mullen Y; Nomura Y; Watanabe Y; Brunicardi FC; Anderson C; Zinner MJ; Passaro EP J Surg Res; 1994 Apr; 56(4):367-71. PubMed ID: 8152232 [TBL] [Abstract][Full Text] [Related]
15. Permanent acceptance of mitomycin C-treated islet allograft. Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788 [TBL] [Abstract][Full Text] [Related]
16. Assessment of long-term (1 year) graft survival and metabolic and hormonal changes after intrasplenic canine pancreatic microfragment transplantation. Marchetti P; Olack B; Swanson C; Newton M; Scharp DW Diabete Metab; 1993; 19(1):17-24. PubMed ID: 8504880 [TBL] [Abstract][Full Text] [Related]
17. Antilymphocyte globulin and renal transplantation. Tagnon A Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848 [TBL] [Abstract][Full Text] [Related]